查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1933386

全球細胞庫市場：市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的考察、未來預測（2026-2034）

Stem Cell Banking Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 261 Pages | 商品交期: 請詢問到貨日

價格

細胞庫市場成長驅動因子

2025年全球細胞庫市場規模達48.1億美元，預計2026年將達50.1億美元。預計到2034年將成長至82.2億美元，預測期內年複合成長率（CAGR）為6.38%。北美地區將引領市場，2025年市場佔有率將達到35.16%，這主要得益於其先進的醫療保健基礎設施、慢性病高發生率以及臍帶血庫和組織庫的廣泛應用。

細胞庫是指收集、處理和保存幹細胞，以備未來醫療應用。遺傳性疾病、癌症和心血管疾病等慢性疾病的日益普遍，以及幹細胞採集、處理和保存技術的進步，推動全球幹細胞年產量的成長。 Cordlife、CBR Systems, Inc. 和 LifeCell International Pvt. Ltd. 等公司投資拓展幹細胞的應用，包括個人化幹細胞庫解決方案，進一步推動市場成長。根據美國癌症協會2025年的資料，預計美國將新增約200萬例癌症病例，凸顯了再生醫學和幹細胞保存服務日益成長的需求。

市場動態

市場驅動因素

慢性疾病的成長趨勢

由於鐮狀細胞貧血、糖尿病和癌症等慢性疾病，需要進行幹細胞移植的患者群體不斷擴大，這推動了對細胞庫的需求。根據美國血液學會2025年的資料，美國有7萬至10萬人患有鐮狀細胞貧血症。臍帶血庫和成人捐贈者登記數量的增加也提高了配型率，尤其是在代表性不足的群體中，並促進了年度幹細胞採集量的成長。

其他顯著的驅動因素包括：人們對再生醫學的認識不斷提高，孕產婦保健意識的增強促進了臍帶血和組織庫的建立，以及對生物樣本庫基礎設施和自動化儲存解決方案的投資。公私合作和政府對幹細胞研究的支持也進一步推動了市場擴張。

市場限制因子

細胞庫成本高

細胞庫需要先進的低溫系統、無菌物流和符合GMP標準的實驗室，這些都是資本密集的。根據《2025年臍帶血庫展望》，在美國，臍帶血的採集和處理成本在1675美元至2820美元之間，這限制了其在中低收入地區的普及。新興國家高昂的營運成本和嚴格的償付政策進一步限制了市場成長。

市場機會

幹細胞應用範圍的擴大

幹細胞的臨床應用範圍不斷擴大，包括治療心肌梗塞、脊髓損傷和肝硬化，這帶來了巨大的商機。越來越多的使用胚胎幹細胞、誘導多能幹細胞和臍帶血幹細胞的臨床試驗推動對高品質保存服務的需求。到2025年，全球將有115項使用人類多能幹細胞的臨床試驗進行中（Elsevier，2025）。基因編輯技術（例如 CRISPR-Cas9）的整合進一步拓展了潛在應用範圍，推動了對個人化生物保險的需求。

市場挑戰

監理與倫理考量

各國嚴格且不同的監管規定，例如美國的FDA 標準和 FACT 認證以及歐盟的組織和細胞指令，限制了市場滲透率。圍繞胚胎幹細胞的倫理問題也限制了研究和商業應用。根據 Springer Nature 發布的2025年報告，幹細胞政策較為嚴格的國家（例如德國和法國）所進行中的臨床試驗數量少於監管較為寬鬆的國家。

市場趨勢

對個人化生物保險的需求不斷成長

人們對個人化醫療的認識不斷提高，推動了透過私人生物保險庫進行生物保險的需求。到2024年，全球私人血庫將儲存約 400萬單位臍帶血（Consumer Affairs 2024）。細胞庫目前提供客製化的儲存方案和多來源儲存，涵蓋臍帶血、臍帶組織和脂肪組織來源的幹細胞，這反映了個人化醫療的發展趨勢。

其他趨勢包括區域性血庫的整合與合併、冷凍保存技術的改進、線上註冊模式以及醫院、診斷實驗室和生物樣本庫之間的合作。

市場區隔分析

依細胞類型

到2026年，臍帶血/臍帶組織來源的幹細胞將佔據市場主導地位，市場佔有率達 59.98%，這主要得益於慢性病患病率的上升和個性化血庫的擴展。預計脂肪組織來源的幹細胞將以 6.6%的年複合成長率成長。

依服務類型

到2026年，標本保存和儲存將以42.16%的市場佔有率佔據主導地位，這主要得益於臨床試驗和再生醫學應用的成長。標本處理預計將以6.2%的年複合成長率成長。

依細胞庫類型

到2026年，私人細胞庫將以63.95%的市場佔有率佔據主導地位，這主要得益於臍帶血採集數量的增加以及人們對個性化細胞庫認知的提高。混合型細胞庫預計將以6.9%的年複合成長率成長。

依應用

到2026年，個人化細胞庫應用將佔據最大的市場佔有率，達到56.16%，這主要得益於對生物保險和幹細胞療法應用的需求不斷成長。研究應用預計將以6.1%的年複合成長率成長。

區域展望

北美將持續維持領先地位，2025年市場規模將達到16.9億美元，2026年將達到17.7億美元，主要得益於美國每年新增3萬株的產量成長。歐洲市場在2025年將達到15.4億美元，而德國、英國和法國在2026年將分別紀錄3.3億美元、2.9億美元和2.5億美元的市場規模。到2025年，亞太地區的市場規模達到12.3億美元，而印度和中國在2026年將分別達到2.9億美元和3.6億美元。拉丁美洲和中東及非洲在2025年的市場規模分別為1.9億美元和8,000萬美元。

目錄

第1章 引言

第2章 執行摘要

第3章 市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機會
  • 市場趨勢

第4章 主要考察

  • 主要國家/地區主要疾病盛行率（2025/2026）
  • 主要國家/地區監理概覽（2025/2026）
  • 主要產業趨勢：併購、業務合作

第5章 全球細胞庫市場分析：洞察與預測（2021-2034）

  • 市場分析、洞察與預測：依細胞類型劃分
    • 週邊血幹細胞
    • 骨髓細胞
    • 脂肪組織來源幹細胞
    • 臍帶血/結締組織來源幹細胞
    • 其他
  • 市場分析、洞察與預測：依服務類型劃分
    • 樣本保存與儲存
    • 樣本分析
    • 樣本處理
    • 採樣和運輸
  • 市場分析、洞察與預測：依細胞庫類型劃分
    • 公共細胞庫
    • 私人細胞庫
    • 混合型細胞庫
  • 市場分析、洞察與預測：依應用劃分
    • 研究應用
    • 臨床應用
    • 個人化細胞庫應用
  • 市場分析、洞察與預測：依地區劃分
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第6章 北美細胞庫市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 美國各州
    • 加拿大

第7章 歐洲細胞庫市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 斯堪的納維亞

第8章 亞太地區細胞庫市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 日本
    • 澳洲
    • 中國
    • 印度
    • 東南亞
    • 亞太其他地區

第9章 拉丁美洲細胞庫市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區

第10章 中東與非洲細胞庫市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • GCC國家
    • 南非
    • 中東和非洲其他地區

第11章 競爭分析

  • 全球市場佔有率分析（2026）
  • 公司簡介
  • CBR Systems, Inc.
  • LifeCell International Pvt. Ltd.
  • Cordlife
  • Cryo-Cell International, Inc.
  • ViaCord
  • Cryoviva
  • Biocell
  • CryoSave South Africa（Pty）Ltd.
Product Code: FBI114449

Growth Factors of stem cell banking Market

The global stem cell banking market was valued at USD 4.81 billion in 2025 and is projected to reach USD 5.01 billion in 2026, eventually growing to USD 8.22 billion by 2034, exhibiting a CAGR of 6.38% during the forecast period. North America dominated the market in 2025 with a 35.16% share, attributed to the advanced healthcare infrastructure, high prevalence of chronic disorders, and widespread adoption of cord blood and tissue banking.

Stem cell banking involves collecting, processing, and storing stem cells for potential future medical applications. Rising prevalence of chronic conditions such as genetic disorders, cancer, and cardiovascular diseases, coupled with advancements in stem cell collection, processing, and storage technologies, has driven annual collections globally. Companies such as Cordlife, CBR Systems, Inc., and LifeCell International Pvt. Ltd. are investing in expanding stem cell applications, including personalized banking solutions, further supporting market growth. According to 2025 data from the American Cancer Society, around 2.0 million new cancer cases are projected in the U.S., highlighting the growing need for regenerative therapies and stem cell storage services.

Market Dynamics

Market Drivers

Rising Prevalence of Chronic Diseases

The growing patient pool for stem cell transplantation due to chronic disorders, such as sickle cell disease, diabetes, and cancer, is driving demand for stem cell banking. In the U.S., 70,000-100,000 individuals live with sickle cell disease, according to the American Society of Hematology 2025. Increased registries of cord blood units and adult donors also improve match rates, especially for underrepresented groups, boosting annual stem cell collections.

Other notable drivers include growing awareness of regenerative medicine, rising maternal healthcare awareness promoting cord blood/tissue banking, and investments in biobanking infrastructure and automated storage solutions. Public-private partnerships and governmental support for stem cell research further encourage market expansion.

Market Restraints

High Cost of Stem Cell Banking

Stem cell banking requires advanced cryogenic systems, sterile logistics, and GMP-compliant laboratories, which are capital-intensive. According to Cord Blood Banking 2025, collection and processing costs in the U.S. range between USD 1,675 and USD 2,820, limiting adoption in low- and middle-income regions. High operational expenditure and limited reimbursement policies in emerging nations further constrain market growth.

Market Opportunities

Expansion of Stem Cell Applications

Widening clinical applications, including treatments for myocardial infarction, spinal cord injuries, and liver cirrhosis, present lucrative opportunities. The increasing number of clinical trials involving embryonic, induced, and cord-blood-derived stem cells enhances demand for high-quality storage services. In 2025, 115 clinical trials involving human pluripotent stem cells were underway globally (Elsevier Inc., 2025). Integration of genetic editing technologies like CRISPR-CAS9 further expands potential applications, driving personalized banking demand.

Market Challenges

Regulatory and Ethical Considerations

Stringent and varied regulations across countries, such as FDA standards and FACT accreditation in the U.S., or the European Tissue and Cells Directive, limit market penetration. Ethical concerns surrounding embryonic stem cells also restrict research and commercial adoption. According to Springer Nature 2025, countries with stricter stem cell policies, including Germany and France, conducted fewer clinical trials compared to more permissive nations.

Market Trends

Increasing Demand for Personalized Banking

Growing awareness of personalized medicine has augmented demand for biological insurance through private banking. Approximately 4 million cord blood units were stored in private banks globally by 2024 (Consumer Affairs 2024). Stem cell banks now offer customized storage plans and multi-source preservation for cord blood, cord tissue, and adipose tissue-derived stem cells, reflecting the trend toward personalized healthcare.

Other trends include consolidation and mergers among regional banks, technological improvements in cryopreservation, online enrollment models, and collaborations between hospitals, diagnostic labs, and biobanks.

Segmentation Analysis

By Cell Type

The CB/CT-derived stem cells segment dominated in 2026 with 59.98% share, driven by the rising prevalence of chronic disorders and expansion of personalized banking. Adipose tissue-derived stem cells are projected to grow at a CAGR of 6.6%.

By Service Type

Sample preservation and storage led the market with 42.16% share in 2026, fueled by increasing clinical trials and regenerative therapy applications. Sample processing is expected to grow at a CAGR of 6.2%.

By Bank Type

The private segment dominated with a 63.95% share in 2026, due to higher cord blood collections and growing awareness of personalized banking. The hybrid segment is projected to grow at 6.9% CAGR.

By Application

Personalized banking applications held the dominant share in 2026 at 56.16%, supported by the growing demand for biological insurance and therapeutic use of stem cells. Research applications are projected to grow at 6.1% CAGR.

Regional Outlook

North America led with USD 1.69 billion in 2025 and USD 1.77 billion in 2026, primarily driven by U.S. collections totaling 30,000 new units annually. Europe reached USD 1.54 billion in 2025, with Germany, the U.K., and France recording USD 0.33 billion, USD 0.29 billion, and USD 0.25 billion in 2026, respectively. Asia Pacific was valued at USD 1.23 billion in 2025, with India and China reaching USD 0.29 billion and USD 0.36 billion in 2026. Latin America and Middle East & Africa were at USD 0.19 billion and USD 0.08 billion in 2025, respectively.

Competitive Landscape

Key players include CBR Systems, Inc., LifeCell International Pvt. Ltd., Cordlife, Cryo-Cell International, Inc., ViaCord, Cryoviva, Biocell, and CryoSave South Africa (Pty) Ltd. Strategic initiatives such as LifeCell's 2024 solution launch and Cryo-Cell's patent agreement with Duke University in 2023 highlight efforts to strengthen market presence globally.

Conclusion

The global stem cell banking market is projected to grow from USD 5.01 billion in 2026 to USD 8.22 billion by 2034, driven by increasing chronic disease prevalence, personalized medicine, technological advancements in storage and processing, and rising clinical trial activities. North America continues to dominate, while emerging regions such as Asia Pacific and Latin America present lucrative growth opportunities. Despite cost and regulatory challenges, the expansion of therapeutic applications and rising awareness of biological insurance are expected to sustain market growth through 2034.

Segmentation By Cell Type, Service Type, Bank Type, Application, and Region

By Cell Type * Peripheral Blood Stem Cells

  • Bone Marrow Cells
  • Adipose Tissue-Derived Stem Cells
  • CB/CT Derived Stem Cells
  • Others

By Service Type * Sample Preservation and Storage

  • Sample Analysis
  • Sample Processing
  • Sample Collection and Transportation

By Bank Type * Public

  • Private
  • Hybrid

By Application * Research Applications

  • Clinical Applications
  • Personalized Banking Applications

By Region * North America (By Cell Type, By Service Type, By Bank Type, By Application, and by Country)

    • U.S. (By Bank Type)
    • Canada (By Bank Type)
  • Europe (By Cell Type, By Service Type, By Bank Type, By Application, and by Country/Sub-region)
    • U.K. (By Bank Type)
    • Germany (By Bank Type)
    • France (By Bank Type)
    • Italy (By Bank Type)
    • Spain (By Bank Type)
    • Scandinavia (By Bank Type)
    • Rest of Europe (By Bank Type)
  • Asia Pacific (By Cell Type, By Service Type, By Bank Type, By Application, and by Country/Sub-region)
    • China (By Bank Type)
    • Japan (By Bank Type)
    • India (By Bank Type)
    • Australia (By Bank Type)
    • Southeast Asia (By Bank Type)
    • Rest of Asia Pacific (By Bank Type)
  • Latin America (By Cell Type, By Service Type, By Bank Type, By Application, and by Country/Sub-region)
    • Brazil (By Bank Type)
    • Mexico (By Bank Type)
    • Rest of Latin America (By Bank Type)
  • Middle East & Africa (By Cell Type, By Service Type, By Bank Type, By Application, and by Country/Sub-region)
    • GCC (By Bank Type)
    • South Africa (By Bank Type)
    • Rest of the Middle East & Africa (By Bank Type)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Key Disorders, Key Countries/Regions, 2025/2026
  • 4.2. Overview of Regulatory Scenario, Key Countries/Regions, 2025/2026
  • 4.3. Key Industry Developments - Mergers, Acquisitions & Partnerships

5. Global Stem Cell Banking Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Cell Type
    • 5.1.1. Peripheral Blood Stem Cells
    • 5.1.2. Bone Marrow Cells
    • 5.1.3. Adipose Tissue-Derived Stem Cells
    • 5.1.4. CB/CT Derived Stem Cells
    • 5.1.5. Others
  • 5.2. Market Analysis, Insights and Forecast - By Service Type
    • 5.2.1. Sample Preservation and Storage
    • 5.2.2. Sample Analysis
    • 5.2.3. Sample Processing
    • 5.2.4. Sample Collection and Transportation
  • 5.3. Market Analysis, Insights and Forecast - By Bank Type
    • 5.3.1. Public
    • 5.3.2. Private
    • 5.3.3. Hybrid
  • 5.4. Market Analysis, Insights and Forecast - By Application
    • 5.4.1. Research Applications
    • 5.4.2. Clinical Applications
    • 5.4.3. Personalized Banking Applications
  • 5.5. Market Analysis, Insights and Forecast - By Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa

6. North America Stem Cell Banking Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Cell Type
    • 6.1.1. Peripheral Blood Stem Cells
    • 6.1.2. Bone Marrow Cells
    • 6.1.3. Adipose Tissue-Derived Stem Cells
    • 6.1.4. CB/CT Derived Stem Cells
    • 6.1.5. Others
  • 6.2. Market Analysis, Insights and Forecast - By Service Type
    • 6.2.1. Sample Preservation and Storage
    • 6.2.2. Sample Analysis
    • 6.2.3. Sample Processing
    • 6.2.4. Sample Collection and Transportation
  • 6.3. Market Analysis, Insights and Forecast - By Bank Type
    • 6.3.1. Public
    • 6.3.2. Private
    • 6.3.3. Hybrid
  • 6.4. Market Analysis, Insights and Forecast - By Application
    • 6.4.1. Research Applications
    • 6.4.2. Clinical Applications
    • 6.4.3. Personalized Banking Applications
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
      • 6.5.1.1. By Bank Type
    • 6.5.2. Canada
      • 6.5.2.1. By Bank Type

7. Europe Stem Cell Banking Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Cell Type
    • 7.1.1. Peripheral Blood Stem Cells
    • 7.1.2. Bone Marrow Cells
    • 7.1.3. Adipose Tissue-Derived Stem Cells
    • 7.1.4. CB/CT Derived Stem Cells
    • 7.1.5. Others
  • 7.2. Market Analysis, Insights and Forecast - By Service Type
    • 7.2.1. Sample Preservation and Storage
    • 7.2.2. Sample Analysis
    • 7.2.3. Sample Processing
    • 7.2.4. Sample Collection and Transportation
  • 7.3. Market Analysis, Insights and Forecast - By Bank Type
    • 7.3.1. Public
    • 7.3.2. Private
    • 7.3.3. Hybrid
  • 7.4. Market Analysis, Insights and Forecast - By Application
    • 7.4.1. Research Applications
    • 7.4.2. Clinical Applications
    • 7.4.3. Personalized Banking Applications
  • 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.5.1. U.K.
      • 7.5.1.1. By Bank Type
    • 7.5.2. Germany
      • 7.5.2.1. By Bank Type
    • 7.5.3. France
      • 7.5.3.1. By Bank Type
    • 7.5.4. Spain
      • 7.5.4.1. By Bank Type
    • 7.5.5. Italy
      • 7.5.5.1. By Bank Type
    • 7.5.6. Scandinavia
  • 7.6. By Bank Type
    • 7.6.1. Rest of Europe
      • 7.6.1.1. By Bank Type

8. Asia Pacific Stem Cell Banking Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Cell Type
    • 8.1.1. Peripheral Blood Stem Cells
    • 8.1.2. Bone Marrow Cells
    • 8.1.3. Adipose Tissue-Derived Stem Cells
    • 8.1.4. CB/CT Derived Stem Cells
    • 8.1.5. Others
  • 8.2. Market Analysis, Insights and Forecast - By Service Type
    • 8.2.1. Sample Preservation and Storage
    • 8.2.2. Sample Analysis
    • 8.2.3. Sample Processing
    • 8.2.4. Sample Collection and Transportation
  • 8.3. Market Analysis, Insights and Forecast - By Bank Type
    • 8.3.1. Public
    • 8.3.2. Private
    • 8.3.3. Hybrid
  • 8.4. Market Analysis, Insights and Forecast - By Application
    • 8.4.1. Research Applications
    • 8.4.2. Clinical Applications
    • 8.4.3. Personalized Banking Applications
  • 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.5.1. Japan
      • 8.5.1.1. By Bank Type
    • 8.5.2. Australia
      • 8.5.2.1. By Bank Type
    • 8.5.3. China
      • 8.5.3.1. By Bank Type
    • 8.5.4. India
      • 8.5.4.1. By Bank Type
    • 8.5.5. Southeast Asia
      • 8.5.5.1. By Bank Type
    • 8.5.6. Rest of Asia Pacific
      • 8.5.6.1. By Bank Type

9. Latin America Stem Cell Banking Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Cell Type
    • 9.1.1. Peripheral Blood Stem Cells
    • 9.1.2. Bone Marrow Cells
    • 9.1.3. Adipose Tissue-Derived Stem Cells
    • 9.1.4. CB/CT Derived Stem Cells
    • 9.1.5. Others
  • 9.2. Market Analysis, Insights and Forecast - By Service Type
    • 9.2.1. Sample Preservation and Storage
    • 9.2.2. Sample Analysis
    • 9.2.3. Sample Processing
    • 9.2.4. Sample Collection and Transportation
  • 9.3. Market Analysis, Insights and Forecast - By Bank Type
    • 9.3.1. Public
    • 9.3.2. Private
    • 9.3.3. Hybrid
  • 9.4. Market Analysis, Insights and Forecast - By Application
    • 9.4.1. Research Applications
    • 9.4.2. Clinical Applications
    • 9.4.3. Personalized Banking Applications
  • 9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.5.1. Brazil
      • 9.5.1.1. By Bank Type
    • 9.5.2. Mexico
      • 9.5.2.1. By Bank Type
    • 9.5.3. Rest of Latin America
      • 9.5.3.1. By Bank Type

10. Middle East & Africa Stem Cell Banking Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Cell Type
    • 10.1.1. Peripheral Blood Stem Cells
    • 10.1.2. Bone Marrow Cells
    • 10.1.3. Adipose Tissue-Derived Stem Cells
    • 10.1.4. CB/CT Derived Stem Cells
    • 10.1.5. Others
  • 10.2. Market Analysis, Insights and Forecast - By Service Type
    • 10.2.1. Sample Preservation and Storage
    • 10.2.2. Sample Analysis
    • 10.2.3. Sample Processing
    • 10.2.4. Sample Collection and Transportation
  • 10.3. Market Analysis, Insights and Forecast - By Bank Type
    • 10.3.1. Public
    • 10.3.2. Private
    • 10.3.3. Hybrid
  • 10.4. Market Analysis, Insights and Forecast - By Application
    • 10.4.1. Research Applications
    • 10.4.2. Clinical Applications
    • 10.4.3. Personalized Banking Applications
  • 10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.5.1. GCC
      • 10.5.1.1. By Bank Type
    • 10.5.2. South Africa
      • 10.5.2.1. By Bank Type
    • 10.5.3. Rest of the Middle East & Africa
      • 10.5.3.1. By Bank Type

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2026)
  • 11.2. Company Profiles (Overview, Services, SWOT analysis, Recent developments, strategies, financials (based on availability))
    • 11.2.1. CBR Systems, Inc.
    • 11.2.2. LifeCell International Pvt. Ltd.
    • 11.2.3. Cordlife
    • 11.2.4. Cryo-Cell International, Inc.
    • 11.2.5. ViaCord
    • 11.2.6. Cryoviva
    • 11.2.7. Biocell
    • 11.2.8. CryoSave South Africa (Pty) Ltd.

List of Tables

  • Table 1: Global Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Cell Type, 2021-2034
  • Table 2: Global Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Service Type, 2021-2034
  • Table 3: Global Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Bank Type, 2021-2034
  • Table 4: Global Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Application, 2021-2034
  • Table 5: Global Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Region, 2021-2034
  • Table 6: North America Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Cell Type, 2021-2034
  • Table 7: North America Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Service Type, 2021-2034
  • Table 8: North America Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Bank Type, 2021-2034
  • Table 9: North America Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Application, 2021-2034
  • Table 10: North America Stem Cell Banking Market Revenue (USD BIllion) Forecast, By Country, 2021-2034
  • Table 11: U.S. Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Bank Type, 2021-2034
  • Table 12: Canada Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Bank Type, 2021-2034
  • Table 13: Europe Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Cell Type, 2021-2034
  • Table 14: Europe Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Service Type, 2021-2034
  • Table 15: Europe Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Bank Type, 2021-2034
  • Table 16: Europe Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Application, 2021-2034
  • Table 17: Europe Stem Cell Banking Market Revenue (USD BIllion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 18: Germany Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Bank Type, 2021-2034
  • Table 19: U.K. Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Bank Type, 2021-2034
  • Table 20: France Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Bank Type, 2021-2034
  • Table 21: Italy Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Bank Type, 2021-2034
  • Table 22: Spain Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Bank Type, 2021-2034
  • Table 23: Scandinavia Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Bank Type, 2021-2034
  • Table 24: Rest of Europe Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Bank Type, 2021-2034
  • Table 25: Asia Pacific Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Cell Type, 2021-2034
  • Table 26: Asia Pacific Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Service Type, 2021-2034
  • Table 27: Asia Pacific Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Bank Type, 2021-2034
  • Table 28: Asia Pacific Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Application, 2021-2034
  • Table 29: Asia Pacific Stem Cell Banking Market Revenue (USD BIllion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 30: China Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Bank Type, 2021-2034
  • Table 31: Japan Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Bank Type, 2021-2034
  • Table 32: India Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Bank Type, 2021-2034
  • Table 33: Australia Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Bank Type, 2021-2034
  • Table 34: Southeast Asia Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Bank Type, 2021-2034
  • Table 35: Rest of Asia Pacific Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Bank Type, 2021-2034
  • Table 36: Latin America Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Cell Type, 2021-2034
  • Table 37: Latin America Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Service Type, 2021-2034
  • Table 38: Latin America Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Bank Type, 2021-2034
  • Table 39: Latin America Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Application, 2021-2034
  • Table 40: Latin America Stem Cell Banking Market Revenue (USD BIllion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 41: Brazil Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Bank Type, 2021-2034
  • Table 42: Mexico Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Bank Type, 2021-2034
  • Table 43: Rest of Latin America Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Bank Type, 2021-2034
  • Table 44: Middle East & Africa Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Cell Type, 2021-2034
  • Table 45: Middle East & Africa Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Service Type, 2021-2034
  • Table 46: Middle East & Africa Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Bank Type, 2021-2034
  • Table 47: Middle East & Africa Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Application, 2021-2034
  • Table 48: Middle East & Africa Stem Cell Banking Market Revenue (USD BIllion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 49: GCC Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Bank Type, 2021-2034
  • Table 50: South Africa Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Bank Type, 2021-2034
  • Table 51: Rest of the Middle East & Africa Stem Cell Banking Market Revenue (USD BIllion) Forecast, by Bank Type, 2021-2034

List of Figures

  • Figure 1: Global Stem Cell Banking Market Revenue Breakdown (USD BIllion, %) by Region, 2026 & 2034
  • Figure 2: Global Stem Cell Banking Market Value Share (%), by Cell Type, 2026 & 2034
  • Figure 3: Global Stem Cell Banking Market Value Share (%), by Service Type, 2026 & 2034
  • Figure 4: Global Stem Cell Banking Market Value Share (%), by Bank Type, 2026 & 2034
  • Figure 5: Global Stem Cell Banking Market Value Share (%), by Application, 2026 & 2034
  • Figure 6: Global Stem Cell Banking Market Value Share (%), by Region, 2026 & 2034
  • Figure 7: North America Stem Cell Banking Market Value (USD BIllion), by Cell Type, 2026 & 2034
  • Figure 8: North America Stem Cell Banking Market Value Share (%), by Cell Type, 2026
  • Figure 9: North America Stem Cell Banking Market Value (USD BIllion), by Service Type, 2026 & 2034
  • Figure 10: North America Stem Cell Banking Market Value Share (%), by Service Type, 2026
  • Figure 11: North America Stem Cell Banking Market Value (USD BIllion), by Bank Type, 2026 & 2034
  • Figure 12: North America Stem Cell Banking Market Value Share (%), by Bank Type, 2026
  • Figure 13: North America Stem Cell Banking Market Value (USD BIllion), by Application, 2026 & 2034
  • Figure 14: North America Stem Cell Banking Market Value Share (%), by Application, 2026
  • Figure 15: North America Stem Cell Banking Market Value (USD BIllion), By Country, 2026 & 2034
  • Figure 16: North America Stem Cell Banking Market Value Share (%), By Country, 2026
  • Figure 17: Europe Stem Cell Banking Market Value (USD BIllion), by Cell Type, 2026 & 2034
  • Figure 18: Europe Stem Cell Banking Market Value Share (%), by Cell Type, 2026
  • Figure 19: Europe Stem Cell Banking Market Value (USD BIllion), by Service Type, 2026 & 2034
  • Figure 20: Europe Stem Cell Banking Market Value Share (%), by Service Type, 2026
  • Figure 21: Europe Stem Cell Banking Market Value (USD BIllion), by Bank Type, 2026 & 2034
  • Figure 22: Europe Stem Cell Banking Market Value Share (%), by Bank Type, 2026
  • Figure 23: Europe Stem Cell Banking Market Value (USD BIllion), by Application, 2026 & 2034
  • Figure 24: Europe Stem Cell Banking Market Value Share (%), by Application, 2026
  • Figure 25: Europe Stem Cell Banking Market Value (USD BIllion), By Country/ Sub-region, 2026 & 2034
  • Figure 26: Europe Stem Cell Banking Market Value Share (%), By Country/ Sub-region, 2026
  • Figure 27: Asia Pacific Stem Cell Banking Market Value (USD BIllion), by Cell Type, 2026 & 2034
  • Figure 28: Asia Pacific Stem Cell Banking Market Value Share (%), by Cell Type, 2026
  • Figure 29: Asia Pacific Stem Cell Banking Market Value (USD BIllion), by Service Type, 2026 & 2034
  • Figure 30: Asia Pacific Stem Cell Banking Market Value Share (%), by Service Type, 2026
  • Figure 31: Asia Pacific Stem Cell Banking Market Value (USD BIllion), by Bank Type, 2026 & 2034
  • Figure 32: Asia Pacific Stem Cell Banking Market Value Share (%), by Bank Type, 2026
  • Figure 33: Asia Pacific Stem Cell Banking Market Value (USD BIllion), by Application, 2026 & 2034
  • Figure 34: Asia Pacific Stem Cell Banking Market Value Share (%), by Application, 2026
  • Figure 35: Asia Pacific Stem Cell Banking Market Value (USD BIllion), By Country/ Sub-region, 2026 & 2034
  • Figure 36: Asia Pacific Stem Cell Banking Market Value Share (%), By Country/ Sub-region, 2026
  • Figure 37: Latin America Stem Cell Banking Market Value (USD BIllion), by Cell Type, 2026 & 2034
  • Figure 38: Latin America Stem Cell Banking Market Value Share (%), by Cell Type, 2026
  • Figure 39: Latin America Stem Cell Banking Market Value (USD BIllion), by Service Type, 2026 & 2034
  • Figure 40: Latin America Stem Cell Banking Market Value Share (%), by Service Type, 2026
  • Figure 41: Latin America Stem Cell Banking Market Value (USD BIllion), by Bank Type, 2026 & 2034
  • Figure 42: Latin America Stem Cell Banking Market Value Share (%), by Bank Type, 2026
  • Figure 43: Latin America Stem Cell Banking Market Value (USD BIllion), by Application, 2026 & 2034
  • Figure 44: Latin America Stem Cell Banking Market Value Share (%), by Application, 2026
  • Figure 45: Latin America Stem Cell Banking Market Value (USD BIllion), By Country/ Sub-region, 2026 & 2034
  • Figure 46: Latin America Stem Cell Banking Market Value Share (%), By Country/ Sub-region, 2026
  • Figure 47: Middle East & Africa Stem Cell Banking Market Value (USD BIllion), by Cell Type, 2026 & 2034
  • Figure 48: Middle East & Africa Stem Cell Banking Market Value Share (%), by Cell Type, 2026
  • Figure 49: Middle East & Africa Stem Cell Banking Market Value (USD BIllion), by Service Type, 2026 & 2034
  • Figure 50: Middle East & Africa Stem Cell Banking Market Value Share (%), by Service Type, 2026
  • Figure 51: Middle East & Africa Stem Cell Banking Market Value (USD BIllion), by Bank Type, 2026 & 2034
  • Figure 52: Middle East & Africa Stem Cell Banking Market Value Share (%), by Bank Type, 2026
  • Figure 53: Middle East & Africa Stem Cell Banking Market Value (USD BIllion), by Application, 2026 & 2034
  • Figure 54: Middle East & Africa Stem Cell Banking Market Value Share (%), by Application, 2026
  • Figure 55: Middle East & Africa Stem Cell Banking Market Value (USD BIllion), By Country/ Sub-region, 2026 & 2034
  • Figure 56: Middle East & Africa Stem Cell Banking Market Value Share (%), By Country/ Sub-region, 2026
  • Figure 57: Global Stem Cell Banking Market Share (%), By Company, 2026